Investor Insight With a strategic foothold in Portugal and a commodity focus on tungsten – a metal deemed critical by both NATO and US defense agencies – Allied Critical Minerals is advancing two past-producing projects…
admin
-
-
– Highlights Cygnus has received firm commitments totalling A$18.3m via a share placement to institutional and sophisticated investors The Placement was priced at A$0.086 per share, being an 8.5% discount to the last sale price…
-
Investor Insight With multiple catalysts ahead, including resource upgrades, expanded production, and further development of its Laverton, Menzies, and Sandstone hubs, Brightstar Resources presents a compelling investment case in a rising gold market. Overview Gold…
-
(TheNewswire) NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC TheNewswire – June 19, 2025 Heritage Mining Ltd. (CSE: HML FRA:Y66) (‘ Heritage ‘ or…
-
Galan Lithium (GLN:AU) has announced A$20 Million Placement to Strategic Partner Download the PDF here. This post appeared first on investingnews.com
-
Lithium Universe (LU7:AU) has announced Prospectus Download the PDF here. This post appeared first on investingnews.com
-
Critical Metals (NASDAQ:CRML) got a boost on Monday (June 16), landing a letter of interest (LOI) for a non-dilutive US$120 million funding package from the Export-Import Bank of the US (EXIM). The funds would be…
-
A court in Bamako has ordered the temporary transfer of operational control of Barrick Mining’s (TSX:ABX,NYSE:B) Loulo-Gounkoto gold-mining complex to a state-appointed administrator for six months. The ruling, handed down on Tuesday (June 17) by…
-
Galan Lithium Limited (ASX:GLN) ( Galan or the Company ) is pleased to announce it has secured a binding commitment for a A$20 million placement ( Placement ) at A$0.11 per share, a 21% premium…
-
Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals, the company announced Friday. TTAM will acquire…